13.26. Inhalant Solutions: Inhalant solutions are considered to be sterile drug products and must be compounded as such under applicable sterile compounding regulations
and rules. All compounders should closely review and be
very familiar with the compounding rules that apply to
their pharmacy practice.
quoted from Oklahoma Board of Pharmacy July 2013 Newsletter
No comments:
Post a Comment